Men and women have different nutritional needs - therefore there are foods that are more important for each to eat. Here are a few, and why they’re important:
- Tomato Sauce - protects against prostate cancer.
- Oysters - boosts zinc intake, which helps with the male reproductive system.
- Broccoli - protects against bladder cancer, which is especially popular in men.
- Peanut Butter - protects against heart disease.
- Watermelon - has tons of potassium, therefore protects against high blood pressure.
- Papaya - contains tons of vitamin C, which protects against gallbladder disease.
- Flaxseed - potential weapon against breast cancer.
- Tofu - High in soy protein, which can lower cholesterol and may minimize menopausal hot flashes and strengthen bone.
- Buffalo Meat - contains a lot of iron, which helps with anemia (this condition occurs more in women.)
- Collard Greens - may help with osteoporosis.
Wine gets all the credit when it comes to health benefits. But research is increasingly showing that it’s not wine but, in fact, simply alcohol that thins your blood, reduces inflammation and improves sensitivity to insulin. So it’s a great time to be a beer lover! In case you need more reasons to chug, here are a few:
- A newly developed non-alcoholic beer may reduce hot flashes in menopausal women. (Hops contain low levels of the same plant estrogens found in soy.)
- Research has shown that certain antioxidants in hops may impede the development of prostate cancer (in large quantities).
- A recent study suggests that other antioxidants found in hops may help soothe chronic inflammation. Illnesses or diseases that may be affected include cardiovascular disease, Alzheimer’s and arthritis.
- Dark-colored beers do not contain more antioxidants than light-colored beers: the color only indicates how longer the malt was roasted.
- A study showed that people who drink a beer or two per day had higher bone density than those who didn’t. This may be linked to a mineral found in beer called silicon, which promotes healthy bones.
- Beer contains antioxidants and some B vitamins. Some even contain a bit of soluble fibre, which has been linked to reduced cholesterol.
Check out WatchMojo’s video on the history of beer:
According to a recent study, Bristish scientists have concluded that taller men are move vulnerable to to develop “rapidly progressive and aggresive prostate cancer.”
This conclusion was made because the same factors that influence height also contribute to increased risk of developing high-grade prostate cancer.
The study showed that every 3.9 inches increase in height is associated with 23 percent higher risk of high-grade prostate tumor.
Continue here to read more.
Being screened for prostate cancer probably seems like a no-brainer to most health-conscious men, given that the disease is the second-most common cancer in American men as well as the second-most deadly, affecting one in six men.But earlier this week the U.S. Preventive Services Task Force, a panel of primary care experts that issues guidelines about clinical preventive services, recommended against routine prostate cancer screening for men over age 75. The group concluded there wasn’t proof that early detection was saving men’s lives and that the short-term harms outweighed the potential benefits. Read more…
According to Allison Van Dusen
RARITAN, N.J., May 16 /PRNewswire/ — Veridex, LLC announced today that its licensing collaborator, Laboratory Corporation of America Holdings (LabCorp), has commercially launched a new gene methylation test for prostate cancer. The new assay uses the biological specificity of ‘DNA methylation’ in prostate cancer, detecting the methylation of the gene GST-Pi. Methylation is a modification of DNA that occurs primarily in cancer. Veridex is developing the methylation markers in this tissue assay, GST-Pi, along with other markers, for a urine-based screening test for prostate cancer.
Prostate cancer is the leading cause of cancer death in men in the U.S., with more than 230,000 cases diagnosed annually.
LabCorp licensed the methylation technology from Veridex in 2007. Veridex licensed this technology from OncoMethylome Sciences, S.A. (OMS).
About Veridex
Veridex, LLC, a Johnson & Johnson company, develops cancer diagnostic products that will enable earlier disease detection as well as more accurate staging, monitoring and therapeutic selection. The company is initially developing two complementary product lines: CellSearch(TM) assays that identify, enumerate and characterize circulating tumor cells directly from whole blood; and GeneSearch(TM) assays that use molecular technology to diagnose, stage and more accurately characterize tumors. For additional information, please visit www.veridex.com
DENVER, Sept. 13 /PRNewswire/ — Every three minutes a man finds out he has prostate cancer — the second-leading cause of cancer death in American men. In fact, more than 218,890 cases are expected in 2007, making prostate cancer among men more prevalent than breast cancer among women.
Yet men don’t get checked. That is why the non-profit Prostate Cancer Education Council (PCEC) coordinates free or low-cost screenings for millions of men across the United States each year during Prostate Cancer Awareness Week. The Council, which brings together recognized physicians and researchers, was founded on the fact that prostate cancer is nearly 100 percent survivable if caught in its earliest stages.
“If only men would take annual screening for prostate cancer as seriously as women do for breast cancer,” comments Dr. E. David Crawford, Head of the Urologic Oncology Department at the University of Colorado Health Sciences Center and Founder/Chairman of the PCEC. “Every three minutes an American male discovers he has prostate cancer. This is a staggering statistic, but palatable when tempered with early diagnosis when the disease is at its most curable stage.”
This year, Prostate Cancer Awareness Week (PCAW) will be held Sept. 17 — 22 and will potentially screen thousands of men. With more than 500 screening sites across the United States, nearly every man at risk can get checked. Men are at risk if they are over age 40, or over age 35 if they are African-American or have a family history of the disease.
Screenings during PCAW take about 10 minutes and include a Prostate Specific Antigen (PSA) blood test and a Digital Rectal Exam (DRE) done by a trained professional. Men also can choose to have their cholesterol and testosterone levels checked, as many factors play into overall health awareness and a man’s overall risk for prostate cancer.
With all these factors playing into a man’s understanding of prostate cancer, PCEC has dedicated each day of PCAW to one particular topic relating to the disease. The days are:
Monday, Sept. 17 — General Prostate Cancer Awareness Day
Tuesday, Sept. 18 — Advanced Prostate Cancer Awareness Day
Wednesday, Sept. 19 — Benign Prostatic Hyperplasia (BPH) Awareness Day
Thursday, Sept. 20 — Women, Families & Caregivers Day
Friday, Sept. 21 — Know Your Numbers (Cholesterol, Testosterone, Obesity
& Nutrition) Day
Saturday, Sept. 22 — New Horizons (Innovation, Research & Upcoming
Treatment Options) Day
To find a PCAW screening site near you and for more information on prostate cancer, please visit http://www.pcaw.com or call toll free 866-4PROST8.
Researchers have uncovered and are now able to track a key molecule that plays a role in the development and growth of prostate cancer. This ground-breaking discovery can very well cure the lives of many patients living with the disease.
“A molecule that plays a key role in prostate cancer development — and can predict recurrence — has been identified by researchers at the Mayo Clinic in Rochester, Minn.
The report on the B7-H3 molecule appears Wednesday in the journal Cancer Research.
In the study, Mayo researchers found that almost all normal, pre-malignant and cancerous prostate cells have B7-H3 on their surface.”
Read the article for complete details.
For more information about cancer in general, watch this informative video.
PLAY
